A life-saving cure solution for Menkes Disease, a copper deficiency in young children, is at the center of a licensing agreement by The Texas A&M University System, through Intellectual Property and Commercialization office of AgriLife Research study, and a California-based biopharmaceutical company, Engrail Therapeutics.